Draft Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products

This draft statement describes how we will recover the costs of administering the prescribed list of benefits for medical devices and human tissue products from 1 July 2024 to 30 June 2025.

Downloads

Draft Cost Recovery Implementation Statement – Administration of the Prescribed List of Medical Devices and Human Tissue Products

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Report
Audience:
Health sector
Language:
English
Description:

This draft Cost Recovery Implementation Statement (CRIS):

  • provides information on how the Department of Health and Aged Care implements cost recovery for the administration of the Prescribed List of Benefits for Medical Devices and Human Tissue Products (the Prescribed List)
  • outlines the fees that will apply for the 2024-25 financial year
  • describes the legislative changes to support the administration of cost recovery arrangements relating to the Prescribed List
  • provides estimated expenditure and revenue for the 2024-25 financial year

Stakeholders are invited to provide feedback to plcostrecovery@health.gov.au during the consultation period between 8 May 2024 and 29 May 2024.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.